Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Alzheimer's disease Diagnosed by Infrared Analysis of Leucocytes

By LabMedica International staff writers
Posted on 13 Feb 2012
Infrared analysis of white blood cells may possibly be a promising way to diagnose Alzheimer's disease (AD) more accurately.

The technique, which is noninvasive, fast, and low-cost, measures how much infrared radiation is either emitted or absorbed by white blood cells and measured by spectroscopy. More...


Scientists at the Instituto de Estructura de la Materia (Madrid, Spain) used two-dimensional infrared spectroscopy to measure and compare the infrared radiation emitted or absorbed by the leucocytes of healthy controls, versus those of patients with mild, moderate, and severe Alzheimer's disease. A total of 50 patients with Alzheimer's and 20 healthy controls took part in the study and gave blood samples. The white blood cells or mononuclear leukocytes are thought to carry amyloid-ß peptide in Alzheimer patients.

The infrared spectrum of the film of leucocytes was measured with a 1725X spectrophotometer (Perkin-Elmer; Waltham, MA, USA) with high resolution and obtained as an average of 32 scans. The scientists found significant differences in the range of infrared wavelengths displayed between subjects, which were attributable to the different stages of formation of amyloid-ß structures in the blood cells. The results showed that, with this method, healthy controls could be distinguished from mild and moderate sufferers of Alzheimer's disease. The method is being explored as a tool for early diagnosis.

The analysis showed a good test performance: 90% sensitivity and 90.5% specificity for determinations involving mild and moderate AD patients and age-matched healthy controls, and 82.1% sensitivity and 90.5% specificity for determinations involving patients at the three AD stages, mild, moderate, and severe, and age-matched healthy controls. The study demonstrated that AD is associated with higher percentages of β-structure in mononuclear leukocytes than those in healthy age-matched controls.

The authors concluded that the method they used could potentially offer a more simple detection of alternative biomarkers of Alzheimer's disease. Mononuclear leukocytes seem to offer a stable medium to determine ß-sheet structure levels as a function of disease development. The measurements seem to be more sensitive for earlier stages of Alzheimer's disease, namely mild and moderate. The study was published online on January 21 2012, in the journal Analytical and Bioanalytical Chemistry.

Related Links:
Instituto de Estructura de la Materia
Perkin-Elmer



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.